No Mental Harm With Tirzepatide for Weight Management

In adults with overweight or obesity, with or without T2D and without known major psychopathology, weekly subcutaneous tirzepatide for 72 weeks is not linked to an increased risk for depression.
Medscape Medical News

source https://www.medscape.com/viewarticle/no-mental-harm-tirzepatide-weight-management-2026a10002mt?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors